Method for treating cancer with dihydropyridine calcium antagonist
US10688086B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2016 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Oct 19, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a method for treating a cancer with a dihydropyridine calcium antagonist, which comprises administering, to a cancer patient, a dihydropyridine calcium antagonist in an amount effective in inhibiting the cancer metastasis and reducing the proliferation of cancer cells, so as to achieve the effect of increasing the survival rate of patients with cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.